Back
Innoviva, Inc. 10K Form
Buy
54
INVA
Innoviva, Inc.
Last Price:
$20.00
Seasonality Move:
-0.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INVA News And Ratings
See the #1 stock for the next 7 days that we like better than INVA
INVA Financial Statistics
Sales & Book Value
| Annual Sales: | $372.5M |
|---|---|
| Cash Flow: | $48.6M |
| Price / Cash Flow: | 8.04 |
| Annual Sales: | $13.51 |
| Price / Book: | 1.48 |
Profitability
| EPS (TTM): | 1.39400 |
|---|---|
| Net Income (TTM): | $127.3M |
| Gross Margin: | $296.1M |
| Return on Equity: | 17.06% |
| Return on Assets: | 9.67% |
Innoviva, Inc. Earnings Forecast
Key Innoviva, Inc. Financial Ratios
-
The Gross Profit Margin over the past 25 years for INVA is 79.48%.
-
The Selling, General & Administrative Expenses for INVA have been equal to 31.06% of Gross Profit Margin.
-
The Research & Development expenses have been 3.67% of Revenue.
-
The Interest Expense is 94.94% of Operating Income.
-
The Net Earning history of INVA is 6.28% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 15 years.
Innoviva, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | INVA |
| CUSIP: | 45781M |
| Website: | inva.com |
Debt
| Debt-to-Equity Ratio: | 0.26 |
|---|---|
| Current Ratio: | 14.12 |
| Quick Ratio: | 12.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 55.21 |
|---|---|
| Forward P/E Ratio: | 9.82 |
INVA Technical Analysis vs Fundamental Analysis
Buy
54
Innoviva, Inc. (INVA)
is a Buy
Is Innoviva, Inc. a Buy or a Sell?
-
Innoviva, Inc. stock is rated a BuyThe current Innoviva, Inc. [INVA] share price is $19.99. The Score for INVA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.